Infantile Spasms
SPECIAL INTEREST GROUP
The Infantile Spasms SIG is a national group of clinicians and scientists whose mission is to facilitate collaboration on projects to improve our understanding and care of children with Infantile Spasms. There are multiple ongoing projects currently underway. These projects include IS biomarker discovery and validation, time to treat IS, ISITT2, IS corpus callosotomy, disparities in treatment of IS, machine learning, and variability in 2nd line treatment of spasms.
Our group meets on the second Thursday of the month at Noon EST.
Sig Co-leader
Adam Numis, MD
University of California, San Francisco (UCSF)
-
Dr. Adam L. Numis is a pediatric neurologist and specialist in epilepsy. He focuses on evaluating and caring for children with epilepsy, particularly those with difficult-to-treat seizures.
His research includes evaluating the connection between inflammation and epilepsy. His work attempts to understand how inflammatory markers in the blood could help predict which patients might respond best to a particular antiseizure medications, in particular for a severe type of epilepsy termed infantile spasms. Additionally, his work seeks to understand the role inflammation and genetics may play in epilepsy development in certain at-risk populations, including children with neonatal encephalopathy, traumatic brain injuries, and stroke.
Dr. Numis received his medical degree from Harvard Medical School. He completed a residency in pediatrics at Boston Children's Hospital, a residency in child neurology at UCSF, and fellowships in clinical neurophysiology and epilepsy at the University of California, Los Angeles.
SIG Co-Leader
Emily Spelbrink, MD, PhD
Stanford
-
Dr. Emily M. Spelbrink (Mathews) is a pediatric neurologist in Palo Alto, California and is affiliated with multiple hospitals in the area, including California Pacific Medical Center-Van Ness Campus and California Pacific Medical Center-Pacific Campus. She received her medical degree from University of California San Diego School of Medicine and has been in practice between 11-20 years.